Skip to main content
. 2020 Mar 5;12(3):233. doi: 10.3390/pharmaceutics12030233

Figure 1.

Figure 1

Delivery strategies used for gene therapy directly targeting tumor cells or tumor microenvironment components, their major advantages (preceded by a green checkmark) and disadvantages (preceded by a red cross).